Upregulation of PD-L1 by EML4-ALK fusion protein mediates the immune escape in ALK positive NSCLC: Implication for optional anti-PD-1/PD-L1 immune therapy for ALK-TKIs sensitive and resistant NSCLC patients (Q36821248)
Jump to navigation
Jump to search
scientific article published on 21 December 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Upregulation of PD-L1 by EML4-ALK fusion protein mediates the immune escape in ALK positive NSCLC: Implication for optional anti-PD-1/PD-L1 immune therapy for ALK-TKIs sensitive and resistant NSCLC patients |
scientific article published on 21 December 2015 |
Statements
1 reference
Upregulation of PD-L1 by EML4-ALK fusion protein mediates the immune escape in ALK positive NSCLC: Implication for optional anti-PD-1/PD-L1 immune therapy for ALK-TKIs sensitive and resistant NSCLC patients (English)
1 reference
Yan Huang
1 reference
Wenfeng Fang
1 reference
Shaodong Hong
1 reference
Nan Chen
1 reference
Jianhua Zhan
1 reference
Qing Liu
1 reference
Shiyang Kang
1 reference
Xiaobo He
1 reference
Lin Liu
1 reference
Ting Zhou
1 reference
Jiaxing Huang
1 reference
Ying Chen
1 reference
Tao Qin
1 reference
Yaxiong Zhang
1 reference
Yuxiang Ma
1 reference
Yunpeng Yang
1 reference
Yuanyuan Zhao
1 reference
Li Zhang
1 reference
21 December 2015
1 reference
1 reference
e1094598
1 reference
Identifiers
1 reference
1 reference
1 reference